Feldman, of UCLA Health, discusses a target trial emulation finding azithromycin outperformed roflumilast at preventing COPD exacerbations.
William Feldman, MD
Advertisement
Associate Professor of Medicine and an attending physician in the Division of Pulmonary, Critical Care, Sleep Medicine, Clinical Immunology & Allergy at UCLA. He also serves as director of the Pharmaceutical Policy & Outcomes Lab.
Articles by William Feldman, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Metabolic Dysfunction May Explain Sugar-Sweetened Beverage–Gastric Cancer Link, With Andrew Chan, MD, MPH
2
Sugar-Sweetened Beverages Associated With Increased Gastric Cancer Risk, With Andrew Chan, MD, MPH
3
Microneedle Stamp Enters Phase 1 Trial for Peanut Allergy Immunotherapy
4
Ketamine, Psychedelics Share Neuroimmune Signature in TRD
5